Drug
Covid Higiv
Covid Higiv: highest development phase Phase 1, developed by Emergent BioSolutions. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| COVID-HIGIV NCT04661839 | Phase 1 | COVID-19 |
Latest
No recent events.
Follow Covid Higiv on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.